Financhill
Back

Relmada Therapeutics Quote, Financials, Valuation and Earnings

Sell
25

RLMD
Relmada Therapeutics

Last Price:
3.35
Seasonality Move:
-10.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Relmada Therapeutics Price Quote

$3.35
+0.01 (+-4.01%)
(Updated: May 18, 2024 at 5:52 AM ET)

Relmada Therapeutics Key Stats

Sell
25
Relmada Therapeutics (RLMD) is a Sell

Day range:
$3.32 - $3.50
52-week range:
$2.36 - $7.22
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.4%

Volume:
47K
Avg. volume:
97.6K
1-year change:
7.74%
Market cap:
$100.8M
Revenue:
$0
EPS:
$-3.12

How Much Does Relmada Therapeutics Make?

Data Unavailable

Is Relmada Therapeutics Growing As A Company?

Data Unavailable

Relmada Therapeutics Stock Price Performance

What Is Relmada Therapeutics 52-Week High & Low?

Relmada Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Relmada Therapeutics?

Is Relmada Therapeutics Cash Flow Positive?

  • What Is RLMD Cash Flow From Operations?
    Cash flow from operations (TTM) is -$48.2M
  • What Is Relmada Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $123.3K
  • What Is Relmada Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $20.5M

Relmada Therapeutics Return On Invested Capital

Data Unavailable

Relmada Therapeutics Earnings Date & Stock Price

Relmada Therapeutics Competitors

Relmada Therapeutics Dividend Yield

Data Unavailable

Relmada Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 10.88
Upside from Last Price: 225.6%

Major Shareholders

  • How many RLMD shares are owned by institutional investors?
    17.6M RLMD shares are owned by institutional investors
  • How many RLMD shares are owned by insiders?
    944.3K RLMD shares are owned by insiders